The MBD4 Glu346Lys polymorphism is associated with the risk of cervical cancer in a Chinese population

International Journal of Gynecological Cancer

Volumn 22, Issue 9, 2012, Pages 1552-1556

  Xiong, Xing Dong ^a   Luo, Xi Ping ^b   Liu, Xinguang ^a   Jing, Xia ^a   Zeng, Li Qin ^b   Lei, Ming ^a   Hong, Xiao Shan ^b   Chen, Yu ^b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b GUANGDONG WOMEN AND CHILDREN HOSPITAL   (China)

Author keywords

Cervical cancer; MBD4; Risk; Single nucleotide polymorphism

Indexed keywords

GLUTATHIONE; LYSINE; METHYL CPG BINDING DOMAIN 4; PROTEIN; UNCLASSIFIED DRUG;

ADENOSQUAMOUS CARCINOMA; ADULT; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CODON; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; ENDOMETRIUM CARCINOMA; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SEXUAL INTERCOURSE; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ENDODEOXYRIBONUCLEASES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GLUTAMINE; HUMANS; LYSINE; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; UTERINE CERVICAL NEOPLASMS;

EID: 84872355378     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31826e22e4     Document Type: Article

References (21)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Freitas AC, Gurgel AP, Chagas BS, et al. Susceptibility to cervical cancer: an overview. Gynecol Oncol. 2012;126:304-311.
3. Bellacosa A, Cicchillitti L, Schepis F, et al. MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1. Proc Natl Acad Sci U S A. 1999;96:3969-3974.
4. Petronzelli F, Riccio A, Markham GD, et al. Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase. J Biol Chem. 2000;275:32422-32429.
5. Petronzelli F, Riccio A, Markham GD, et al. Investigation of the substrate spectrum of the human mismatch-specific DNA N-glycosylase MED1 (MBD4): fundamental role of the catalytic domain. J Cell Physiol. 2000;185:473-480.
6. Screaton RA, Kiessling S, Sansom OJ, et al. Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: a potential link between genome surveillance and apoptosis. Proc Natl Acad Sci U S A. 2003;100:5211-5216.
7. Riccio A, Aaltonen LA, Godwin AK, et al. The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat Genet. 1999;23:266-268.
8. Bader S, Walker M, Hendrich B, et al. Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency. Oncogene. 1999;18:8044-8047.
9. Bader S, Walker M, Harrison D. Most microsatellite unstable sporadic colorectal carcinomas carry MBD4 mutations. Br J Cancer. 2000;83:1646-1649.
10. Oliveira S, Ribeiro J, Sousa H, et al. Genetic polymorphisms and cervical cancer development: ATM G5557A and p53bp1 C1236G. Oncol Rep. 2012;27:1188-1192.
11. Hao B, Wang H, Zhou K, et al. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res. 2004;64:4378-4384.
12. Miao R, Gu H, Liu H, et al. Tagging single nucleotide polymorphisms in MBD4 are associated with risk of lung cancer in a Chinese population. Lung Cancer. 2008;62:281-286.
13. Shin MC, Lee SJ, Choi JE, et al. Glu346Lys polymorphism in the methyl-CpG binding domain 4 gene and the risk of primary lung cancer. Jpn J Clin Oncol. 2006;36:483-488.
14. Song JH, Maeng EJ, Cao Z, et al. The Glu346Lys polymorphism and frameshift mutations of the methyl-CpG binding domain 4 gene in gastrointestinal cancer. Neoplasma. 2009;56:343-347.
15. Sakiyama T, Kohno T, Mimaki S, et al. Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int J Cancer. 2005;114:730-737.
16. Xiong XD, Zeng LQ, Xiong QY, et al. Association between the CDC6 G1321A polymorphism and the risk of cervical cancer. Int J Gynecol Cancer. 2010;20:856-861.
17. Dupont WD, Plummer WD. Power and sample size calculations. A review and computer program. Control Clin Trials. 1990;11:116-128.
18. Hendrich B, Hardeland U, Ng HH, et al. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature. 1999;401:301-304.
19. Yamada T, Koyama T, Ohwada S, et al. Frameshift mutations in the MBD4/MED1 gene in primary gastric cancer with high-frequency microsatellite instability. Cancer Lett. 2002;181:115-120.
20. Pinto M, Wu Y, Suriano G, et al. MBD4 mutations are rare in gastric carcinomas with microsatellite instability. Cancer Genet Cytogenet. 2003;145:103-107.
21. Millar CB, Guy J, Sansom OJ, et al. Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science. 2002;297:403-405.